Advertisement
Screener

CalciMedica, Inc. (CALC) Material Contracts

CalciMedica, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-20: Form 8-K; Exhibit 10.1; Description CalciMedica, Inc. Amended 2023 Equity Incentive Plan..
  • 2026-06-24: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement, dated June 23, 2026, by and between CalciMedica, Inc. and each of the Investors party thereto.
  • 2026-06-24: Form 8-K; Exhibit 10.1; Description First Amendment to Loan Documents dated June 23, 2026, by and between CalciMedica, Inc., Avenue Venture Opportunities Fund II, L.P. and Avenue Capital Management II, L.P..
  • 2025-08-12: Form 10-Q; Exhibit 10.2; Description Non-employee Director Compensation Policy, as amended..
FiledFormExhibitDescription
2026-08-208-K10.1CalciMedica, Inc. Amended 2023 Equity Incentive Plan.
2026-06-248-K10.1Form of Securities Purchase Agreement, dated June 23, 2026, by and between CalciMedica, Inc. and each of the Investors party thereto
2026-06-248-K10.1First Amendment to Loan Documents dated June 23, 2026, by and between CalciMedica, Inc., Avenue Venture Opportunities Fund II, L.P. and Avenue Capital Management II, L.P.
2025-08-1210-Q10.2Non-employee Director Compensation Policy, as amended.
2025-03-2710-K10.20Non-Employee Director Compensation Policy.
2025-03-2710-K10.6Offer Letter between CalciMedica, Inc. and Stephen Bardin, MBA, dated November 7, 2024.
2025-03-2710-K10.5Offer Letter between CalciMedica, Inc. and Kenneth A. Stauderman, Ph.D., dated August 29, 2014, as amended.
2025-03-2710-K10.4Offer Letter between CalciMedica, Inc. and Michael Dunn, dated August 29, 2014, as amended.
2025-03-2710-K10.3Offer Letter between CalciMedica, Inc. and Sudarshan Hebbar, M.D., dated August 24, 2015, as amended.
2025-03-058-K10.2Supplement to the Loan and Security Agreement dated February 28, 2025, by and among CalciMedica, Inc., Avenue Capital Management II, L.P., and Avenue Venture Opportunities Fund II, L.P.
2025-03-058-K10.1Loan and Security Agreement dated February 28, 2025, by and among CalciMedica, Inc., Avenue Capital Management II, L.P., and Avenue Venture Opportunities Fund II, L.P.
2024-08-278-K10.1CalciMedica, Inc. 2023 Equity Incentive Plan
2024-01-248-K/A10.2Form of Registration Rights Agreement by and among CalciMedica, Inc. and the persons party thereto
2024-01-248-K/A10.1Securities Purchase Agreement, dated January 19, 2024, by and among CalciMedica, Inc. and the persons party thereto (Corrected)
2024-01-228-K10.2Form of Registration Rights Agreement by and among CalciMedica, Inc. and the persons party thereto
2024-01-228-K10.1Securities Purchase Agreement, dated January 19, 2024, by and among CalciMedica, Inc. and the persons party thereto
2023-05-1210-Q10.9EX-10.9+
2023-03-228-K10.13Form of Amendment to Restricted Stock Unit Award Agreement, dated March 20, 2023, by and between Graybug Vision, Inc. and the Holder party thereto
2023-03-228-K10.12Form of Amendment to Stock Option Award Agreement, dated March 20, 2023, by and between Graybug Vision, Inc. and the Holder party thereto
2023-03-228-K10.11Consulting Agreement, dated as of October 26, 2020, by and between the CalciMedica, Inc. and Danforth Advisors, LLC.
2023-03-228-K10.10CalciMedica, Inc. 2006 Stock Plan and Form of Stock Option Agreement thereunder.
2023-03-228-K10.9CalciMedica, Inc. 2023 Employee Stock Purchase Plan.
2023-03-228-K10.8Forms of Restricted Stock Unit Grant Notice and Unit Award Agreement under CalciMedica, Inc. 2023 Equity Incentive Plan.
2023-03-228-K10.7Forms of Option Grant Notice and Option Agreement under CalciMedica, Inc. 2023 Equity Incentive Plan.
2023-03-228-K10.6CalciMedica, Inc. 2023 Equity Incentive Plan.
2023-03-228-K10.5Offer Letter between CalciMedica, Inc. and Kenneth A. Stauderman, Ph.D., dated August 29, 2014.
2023-03-228-K10.4Offer Letter between CalciMedica, Inc. and Michael Dunn, dated August 29, 2014.
2023-03-228-K10.3Offer Letter between CalciMedica, Inc. and Sudarshan Hebbar, M.D., dated August 24, 2015.
2023-03-228-K10.2Offer Letter between CalciMedica, Inc. and Eric Roberts, dated May 20, 2020.
2023-03-228-K10.1Offer Letter between CalciMedica, Inc. and A. Rachel Leheny, Ph.D., dated May 20, 2020.
2023-03-0910-K10.17Separation Agreement, dated February 28, 2023, between the Registrant and Parisa Zamiri.
2022-11-228-K10.3Form of Lock-Up Agreement, dated November 21, 2022
2022-11-228-K10.2Form of Graybug Vision, Inc. Support Agreement, dated November 21, 2022
2022-11-228-K10.1Form of CalciMedica, Inc. Support Agreement, dated November 21, 2022

Similar stocks

Stock NameCountryMarket CapPE Ratio
TALPHERA, INC. (TLPH)United States$0.060B
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
HYPERION DEFI, INC. (HYPD)United States$0.065B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
XBiotech Inc. (XBIT)United States$0.066B-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99